ArticleScientific reports2025

Rapamycin inhibits tamoxifen-induced endometrial proliferation in vitro as a pilot approach for endometrial protection in breast cancer.

Akiko Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.